Carlton Hofferkamp & Jenks Wealth Management, LLC Abb Vie Inc. Transaction History

Carlton Hofferkamp & Jenks Wealth Management, LLC

$307 Million
Q3 2024

A detailed history of Carlton Hofferkamp & Jenks Wealth Management, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Carlton Hofferkamp & Jenks Wealth Management, LLC holds 10,386 shares of ABBV stock, worth $1.71 Million. This represents 0.67% of its overall portfolio holdings.

Number of Shares

10,386

Previous 10,591 1.94%

Holding current value

$1.71 Million

Previous $1.82 Million 12.94%

% of portfolio

0.67%

Previous 0.74%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 05, 2024	SELL	$163.84 - $199.33 $33,587 - $40,862	-205 Reduced 1.94%	10,386 $2.05 Million
Q2 2024 Jul 31, 2024	BUY	$154.79 - $180.76 $3,560 - $4,157	23 Added 0.22%	10,591 $1.82 Million
Q1 2024 Apr 26, 2024	BUY	$159.82 - $182.1 $6,872 - $7,830	43 Added 0.41%	10,568 $1.92 Million
Q3 2023 Oct 26, 2023	BUY	$133.59 - $154.65 $10,019 - $11,598	75 Added 0.72%	10,525 $1.57 Million
Q2 2023 Aug 07, 2023	BUY	$132.51 - $164.9 $1,325 - $1,649	10 Added 0.1%	10,450 $1.41 Million
Q1 2023 May 11, 2023	SELL	$144.61 - $166.54 $48,155 - $55,457	-333 Reduced 3.09%	10,440 $1.66 Million
Q4 2022 Jan 30, 2023	SELL	$138.31 - $165.87 $9,958 - $11,942	-72 Reduced 0.66%	10,773 $1.74 Million
Q3 2022 Oct 24, 2022	SELL	$134.21 - $153.93 $8,723 - $10,005	-65 Reduced 0.6%	10,845 $1.6 Million
Q2 2022 Jul 12, 2022	BUY	$137.62 - $174.96 $3,440 - $4,374	25 Added 0.23%	10,910 $1.67 Million
Q1 2022 Apr 11, 2022	SELL	$131.98 - $163.75 $36,162 - $44,867	-274 Reduced 2.46%	10,885 $1.9 Million
Q4 2021 Jan 26, 2022	SELL	$107.43 - $135.93 $15,040 - $19,030	-140 Reduced 1.24%	11,159 $1.49 Million
Q3 2021 Nov 09, 2021	BUY	$106.4 - $120.78 $50,114 - $56,887	471 Added 4.35%	11,299 $1.31 Million
Q2 2021 Jul 19, 2021	SELL	$105.21 - $117.21 $7,259 - $8,087	-69 Reduced 0.63%	10,828 $1.27 Million
Q1 2021 Apr 28, 2021	BUY	$102.3 - $112.62 $89,512 - $98,542	875 Added 8.73%	10,897 $1.21 Million
Q4 2020 Jan 20, 2021	SELL	$80.49 - $108.67 $36,220 - $48,901	-450 Reduced 4.3%	10,022 $1.12 Million
Q3 2020 Nov 12, 2020	BUY	$85.91 - $100.83 $168,984 - $198,332	1,967 Added 23.13%	10,472 $1.03 Million
Q2 2020 Jul 30, 2020	BUY	$73.37 - $98.18 $24,505 - $32,792	334 Added 4.09%	8,505 $825,000
Q1 2020 Apr 30, 2020	BUY	$64.5 - $97.79 $101,007 - $153,139	1,566 Added 23.71%	8,171 $684,000
Q4 2019 Jan 28, 2020	BUY	$72.13 - $90.25 $32,530 - $40,702	451 Added 7.33%	6,605 $555,000
Q3 2019 Oct 11, 2019	BUY	$62.98 - $75.72 $94,470 - $113,580	1,500 Added 32.23%	6,154 $458,000
Q2 2019 Jul 18, 2019	BUY	$65.7 - $83.98 $55,253 - $70,627	841 Added 22.06%	4,654 $318,000
Q1 2019 Apr 22, 2019	BUY	$77.14 - $90.79 $60,632 - $71,360	786 Added 25.97%	3,813 $307,000
Q4 2018 Jan 29, 2019	BUY	$77.85 - $96.01 $235,651 - $290,622	3,027 New	3,027 $279,000

Others Institutions Holding ABBV

# of Institutions

3,841

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $292B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Carlton Hofferkamp & Jenks Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Carlton Hofferkamp & Jenks Wealth Management, LLC with notifications on news.

Account

Carlton Hofferkamp & Jenks Wealth Management, LLC Abb Vie Inc. Transaction History